Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Revenues, Net Income Up for 1st Quarter

NEW YORK, May 7 – Venlo, Netherlands-based Qiagen announced today that its net revenues and net income were up for the first quarter ending March 31.

The company reported net sales of $80 million, compared to $70.5 million for the year-ago quarter. The firm had net income of $11 million, compared to $9.5 million for the same quarter in 2002.

The company took a first-quarter charge of $1.6 million for the closure of its Seattle facility in 2002 and reported current assets of $208 million as of March 31.

 

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.